North Springs Resources' Joint Venture Secures Funding Agreement

LAS VEGAS, NV--(Marketwired - Jun 1, 2016) - North Springs Resources Corp. (OTC PINK: NSRS) and its JV partner Island Capital S.A. have entered into an agreement with the Fouani Equity Fund AG. to provide up to 5 million dollars in funding for POTEN. POTEN is a treatment using F.D.A. approved pharmaceuticals for the treatment of erectile dysfunction ("ED"). The erectile dysfunction market is estimated at over 4 billion dollars a year, but unlike other ED drugs, POTEN is effective for people with Type 2 Diabetes.

J. Douglas Pulver, President, states, "The Swiss based Fouani Equity Fund AG. has a proven management team that has raised significant capital in the pharmaceutical and energy sectors. With the new funding agreement in place, POTEN should be available for sale in the 4th quarter of 2016. POTEN is a game changer for many individuals with Type 2 Diabetes that are unable to use the other ED drugs on the market. According to the World Health Organization, 8.5% of men over 18 have Type 2 Diabetes. POTEN will definitely create its own market share with these individuals."

For more information about North Springs Resources Corp's exciting new venture into the pharmaceutical market, please see the website northspringspharmagroup.com.

Safe Harbor Statement: This press release may contain certain forward-looking statements. These statements are any statements that are not of historical fact and may be deemed to be forward-looking statements made by management that express their belief at the time they are made regarding the Company's results of operations, possible profits, financial developments, business activities, and potential for success in various aspects of our operations. You can identify forward-looking statements as those that are not historical in nature, particularly those that use terminology such as "may," "will," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projects," "predicts," "potential," or "continue," or the negative of these similar terms. In evaluating these forward-looking statements, you should consider various factors, including the following: (a) those risks and uncertainties related to general economic conditions, (b) whether we are able to manage our planned growth efficiently and operate profitably, (c) whether we are able to generate sufficient revenues or obtain financing to sustain and grow our operations, and (d) whether we are able to successfully fulfill our primary requirements for cash. The Company's actual results may differ significantly from the results projected in the forward-looking statements. The Company assumes no obligation to update forward-looking statements.